Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — Food and Drug Administration & Stéphane Bancel

6 shared events · Importance 3 · Last updated Aug 29, 2026

Importance
3
Shared Events
6
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
84
Regulatory
United States — Food and Drug Administration: The FDA granted approval for mFLUSIVA, marking a regulatory milestone and demonstrating its role in vaccine oversight despite internal controversies.
Stéphane Bancel: As CEO, Bancel championed the vaccine and highlighted its importance for seniors and the company's future.
Aug 05, 2026 · 105 articles
75
Tech
United States — Food and Drug Administration: The FDA is the regulatory authority that must approve the vaccine. Approval could come as soon as 2027, but the agency's review process and potential political interference from the administration could affect the timeline.
Stéphane Bancel: As CEO of Moderna, Bancel is a key figure in the announcement and the company's strategic direction. The trial success is a personal and professional vindication, and he has stated the vaccine could be approved as soon as 2027.
Aug 19, 2026 · 126 articles
60
Regulatory
United States — Food and Drug Administration: The FDA granted approval for Moderna's updated vaccines, playing a central regulatory role in the event.
Stéphane Bancel: As CEO, Stéphane Bancel announced the approval and highlighted the public health importance, reinforcing leadership.
Aug 27, 2026 · 6 articles
44
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration (FDA) is the regulatory body responsible for approving the mFlusiva vaccine. Its advisory committee's unanimous recommendation is a crucial step towards the vaccine's market entry, despite internal disputes and leadership vacancies.
Stéphane Bancel: Stéphane Bancel, CEO of Moderna, expressed appreciation for the VRBPAC's review and highlighted the potential of mRNA-1010 to offer a new option for seasonal flu prevention, reinforcing the company's commitment to the vaccine.
Jun 18, 2026 · 28 articles
0
Regulatory
Stéphane Bancel: Stéphane Bancel, CEO of Moderna, expressed appreciation for the United States — Food and Drug Administration's engagement and agreement to review the vaccine, highlighting the company's goal to make the flu vaccine available to seniors.
Feb 18, 2026 · 9 articles
0
Regulatory
Stéphane Bancel: Stéphane Bancel, Moderna's CEO, expressed disappointment with the United States — Food and Drug Administration's decision, stating it does not further shared goals of innovation.
Feb 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — Food and Drug Administration and Stéphane Bancel interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.